Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Ronda Copher"'
Autor:
Sarah S. Mougalian, Ronda Copher, Jonathan K. Kish, Lindsay McAllister, Zhixiao Wang, Mary Broscious, David Garofalo, Janna Radtchenko, Bruce A. Feinberg
Publikováno v:
Cancer Medicine, Vol 7, Iss 9, Pp 4371-4378 (2018)
Abstract Introduction Real‐world data are critical to demonstrate the consistency of evidence and external generalizability of randomized controlled trials (RCTs). This study examined characteristics and outcomes of metastatic triple‐negative bre
Externí odkaz:
https://doaj.org/article/b658d3e9e1944667a90dfd4adc7700a6
Autor:
David Huggar, Russell L Knoth, Ronda Copher, Zhun Cao, Craig Lipkin, Ali McBride, Thomas W LeBlanc
Publikováno v:
Future Oncology. 18:3609-3621
Aim: This retrospective, observational study assessed healthcare resource utilization (HCRU) and costs for newly diagnosed acute myeloid leukemia (AML) patients receiving intensive induction chemotherapy. Materials & methods: Adult AML patients with
Autor:
Ashley Tabah, Brenna L. Brady, David Huggar, Krutika Jariwala-Parikh, Krystal Huey, Ronda Copher, Thomas William LeBlanc
Publikováno v:
Journal of Medical Economics. 25:903-911
Acute myeloid leukemia (AML) prognosis is poor, with sustained remission occurring in
Publikováno v:
The Oncologist. 27:228-235
Background This study analyses treatment patterns, health care resource utilization (HCRU), and costs in patients with myelofibrosis (MF) and a subgroup treated with ruxolitinib (RUX). Materials and Methods Treatment patterns, all-cause and MF-relate
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:HSR20-108
Publikováno v:
Cancer Research. 80:P2-08
Background: TNBC disproportionally affects younger women and is the leading cause of cancer-related deaths in women under 40. Treatment burden likely has a greater impact in younger women given employment and/or parental status. Little is known about
Autor:
Andrew J, Klink, Ajeet, Gajra, Russell L, Knoth, Landon, Marshall, Ying, Hou, Ali, McBride, Ronda, Copher
Publikováno v:
Leukemia Research. 122:106946
Enasidenib was approved by the Food and Drug Administration in 2017 for the treatment of patients with relapsed or refractory (RR) acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation. Given limited data in clinical practic
Autor:
Ali McBride, David Huggar, Ronda Copher, Zheng-Yi Zhou, Miriam L. Zichlin, Annika Anderson, Nathaniel Downes, Andrew M. Brunner
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S127
Autor:
Ali McBride, David Huggar, Ronda Copher, Zheng-Yi Zhou, Miriam L. Zichlin, Annika Anderson, Nathaniel Downes, Andrew M. Brunner
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S249
Autor:
Stacey DaCosta Byfield, Francis P. Worden, Debanjana Chatterjee, Prashant Ramesh Joshi, Oluwakayode Adejoro, Ronda Copher
Publikováno v:
Advances in Therapy
Introduction Little is known about real-world use of small molecule kinase inhibitors (SMKI) for advanced thyroid cancer in the United States. This study examined prescribing patterns of SMKI agents recommended by the National Comprehensive Cancer Ce